✦ LIBER ✦

Strategies to circumvent the T315I gatekeeper mutation in the Bcr-Abl tyrosine kinase

✍ Scribed by Bose, Prithviraj; Park, Haeseong; Al-Khafaji, Jawad; Grant, Steven

Book ID: 121080252
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 174 KB
Volume: 2
Category: Article
ISSN: 2213-0489
DOI: 10.1016/j.lrr.2013.02.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The rise and fall of gatekeeper mutation

The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm

✍ Don L. Gibbons; Sabrina Pricl; Hagop Kantarjian; Jorge Cortes; Alfonso Quintás-C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Allosteric inhibition enhances the effic

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I

✍ Afsar Ali Mian, Anna Metodieva, Susanne Badura, Mamduh Khateb, Nili Ruimi, Youse 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 389 KB

Dynamic change of T315I BCR-ABL kinase d

Dynamic change of T315I BCR-ABL kinase domain mutation in Korean chronic myeloid leukaemia patients during treatment with Abl tyrosine kinase inhibitors

✍ Wan-Seok Kim; Dongho Kim; Dong-Wook Kim; Il-Young Kweon; Soo-Hyun Kim; Hyun-Gyun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 1 views

## Abstract We analysed the dynamic change of imatinib‐resistant mutations in BCR‐ABL kinase domain focusing on T315I mutation during dasatinib or nilotinib therapy. Fifty‐five imatinib‐resistant chronic myeloid leukaemia patients (32 patients with imatinib‐resistant mutations and 23 patients witho

Stem cell transplantation for patients w

Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I

✍ Nikolai Velev; Jorge Cortes; Richard Champlin; Dan Jones; Gabriela Rondon; Sergi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

The gatekeeper mutation T315I confers re

The gatekeeper mutation T315I confers resistance against small molecules by increasing or restoring the ABL-kinase activity accompanied by aberrant transphosphorylation of endogenous BCR, even in loss-of-function mutants of BCR/ABL

✍ Mian, A A; Schüll, M; Zhao, Z; Oancea, C; Hundertmark, A; Beissert, T; Ottmann, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 465 KB

The Durable Clearance of the T315I BCR-A

The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge

✍ Franck E. Nicolini; Jean-Claude Chomel; Lydia Roy; Laurence Legros; Kaddour Chab 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 137 KB